Eccogene
Clinical trials sponsored by Eccogene, explained in plain language.
-
New drug combo targets fatty liver disease
Disease control Recruiting nowThis study is testing two new drugs, ECC4703 and ECC0509, to see if they can reduce the amount of fat in the liver of people with MASH, a serious form of fatty liver disease. About 160 adults will be randomly assigned to receive one of the drugs, a combination of both, or a place…
Phase: PHASE2 • Sponsor: Eccogene • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test new liver pill: does it work better with food?
Knowledge-focused Recruiting nowThis early-stage study aims to understand how eating food affects different versions of an experimental drug called ECC4703, which is being developed for a serious liver disease. Researchers will give single doses to about 72 healthy adults to measure how the drug moves through t…
Phase: PHASE1 • Sponsor: Eccogene • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC